These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2662529)

  • 1. The role of class I antigens in hyperacute rejection of hepatic allografts in rats.
    Knechtle SJ; Yamaguchi Y; Harland RC; Coundouriotis A; Bollinger RR
    Transplant Proc; 1989 Jun; 21(3):3557. PubMed ID: 2662529
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of class I major histocompatibility complex antigens on hepatic allograft survival in rats: distribution of donor cells which express class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y; Goto M; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Ogawa M
    Transplant Proc; 1995 Feb; 27(1):540-2. PubMed ID: 7879091
    [No Abstract]   [Full Text] [Related]  

  • 3. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
    Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M
    Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of donor serum to prevent passive transfer of hyperacute rejection.
    Wang J; Geissler EK; Fechner JH; Burlingham WJ; Knechtle SJ
    J Surg Res; 1994 Jul; 57(1):150-5. PubMed ID: 8041130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of passenger leukocytes in the immunogenicity of intestinal and cardiac allografts in the rat.
    Gundlach M; Oluwole S; D'Agati V; Chabot J; Broelsch CE; Hardy MA
    Transplant Proc; 1992 Jun; 24(3):1131-2. PubMed ID: 1604552
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplant Proc; 1989 Jun; 21(3):3555. PubMed ID: 2662527
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor major histocompatibility complex class I antigens.
    Oluwole SF; Chowdhury NC; Fawwaz R; James T; Hardy MA
    Transplant Proc; 1993 Feb; 25(1 Pt 1):299-300. PubMed ID: 8438308
    [No Abstract]   [Full Text] [Related]  

  • 8. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
    Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
    Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of RT1.a major histocompatibility antigens in prolonging the survival of hepatic allografts in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):792-3. PubMed ID: 2650272
    [No Abstract]   [Full Text] [Related]  

  • 11. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
    Fangmann J; Dalchau R; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):183-4. PubMed ID: 8438266
    [No Abstract]   [Full Text] [Related]  

  • 12. A role for MHC antigens in donor-specific blood transfusion for the inhibition of liver allograft rejection in the rat.
    Ishii E; Sumimoto R; Yamaguchi A
    Transplantation; 1992 Oct; 54(4):750-2. PubMed ID: 1412773
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of humoral immunity in pancreatic islet allo- and xenograft rejection.
    Ahn M; Sohn C; Chang E; Chu G; DeMatteo RP; Barker CF; Markmann JF
    Transplant Proc; 1996 Apr; 28(2):840-1. PubMed ID: 8623428
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: in situ splenic distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Jan; 60(1):216-23. PubMed ID: 8592417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: tissue distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Shirakusa T; Ogawa M
    Transplant Proc; 1995 Apr; 27(2):1625-7. PubMed ID: 7725428
    [No Abstract]   [Full Text] [Related]  

  • 16. Accelerated rejection of a skin graft after liver transplantation from a sensitized donor: functional aspects of microchimerism.
    Dahmen U; Tanigawa T; Rogiers X; Lindkaer-Jensen S; Broelsch CE
    Transplant Proc; 1996 Dec; 28(6):3243-5. PubMed ID: 8962256
    [No Abstract]   [Full Text] [Related]  

  • 17. A serine protease inhibitor, N-alpha-tosyl-l-lysine chloromethyl ketone, prolongs rat hepatic allograft survival.
    Zhang JL; Yamaguchi Y; Mori K; Okabe K; Hidaka H; Ohshiro H; Uchino S; Ishihara K; Furuhashi T; Yamada S; Ogawa M
    J Surg Res; 2001 Apr; 96(2):296-303. PubMed ID: 11266287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.
    Shirwan H; Cosenza CA; Wang HK; Wu GD; Makowka L; Cramer DV
    Transplantation; 1994 Apr; 57(7):1072-80. PubMed ID: 8165706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.
    Nakamura K; Murase N; Becich MJ; Furuya T; Todo S; Fung JJ; Starzl TE; Demetris AJ
    Am J Pathol; 1993 May; 142(5):1383-91. PubMed ID: 8494042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.